Alpha Tau Medical Ltd.

NASDAQ:DRTS

Biotechnology

Healthcare
$12.01 +0.42%

+$0.04 today

Market cap
$1.11B
Beta
1.20
P/E (TTM)
-15.2
EPS (TTM)
-$0.63
52W Low $2.85High $11.62

Volume 0.64M

Average 0.69M

DRTS Effect of Forex Changes

Change in reported cash caused by exchange-rate movements on foreign-currency balances.

Alpha Tau Medical Ltd.NASDAQ: DRTS

Effect of Forex Changes · Q4 FY2025 · quarter ended Dec 2025

Effect of forex changes growth accelerates

Q4 FY2025 effect of forex changes of $10.48M rose 27.0% year over year, ahead of the -57.2% change in trailing-twelve-month effect of forex changes.

Context

  • Effect of forex changes increased in 2 of the last 3 fiscal years.

What to watch

Whether quarterly growth of +27.0% holds above the trailing-twelve-month pace of -57.2%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterDec 2025
$10.48M+226.9% QoQ
Last fiscal yearDec 2025
$501K+213.1% YoY
LTMDec 2025
$501K-57.2% YoY
Effect of Forex Changes past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+27.0%——
1 year+213.1%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Effect of Forex Changes history

USD · from the cash flow

Latest · FY2025
501K USD
Year-over-year change
+213.1%
4-year CAGR
+46.8%

Effect of Forex Changes vs competitors

How DRTS compares with its peers on the latest reported figures

  • DRTS's LTM Dec 2025 effect of forex changes of $501K is the largest of the 3 companies compared; the peer median is $0.
DRTS Competitors Peer median
Effect of Forex Changes for DRTS and competitors
Company Period LTM YoY 3-year CAGR% of revenue
DRTSAlpha Tau Medical Ltd.LTM Dec 2025$501K -57.2%——
AKTSAktis Oncology, Inc.FY2025$0 ——0.0%
CATXPerspective Therapeutics, Inc.LTM Mar 2026$0 ——0.0%
Peer median (excluding DRTS) $0——0.0%

Competitors are the stored peer set for DRTS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(27.27M)(33.76M)(29.16M)(31.75M)(42.63M)
Depreciation & Amortization776K979K1.07M1.1M1.23M
Deferred Income Tax00000
Stock-Based Compensation812K6.75M7.93M9.92M0
Change in Working Capital585K(307K)2.49M1.17M2.29M
Accounts Receivables00000
Inventory00000
Accounts Payables239K220K1.14M965K337K
Other Working Capital346K(527K)1.35M203K1.95M
Other Non-Cash Items13.29M2.46M(293K)(219K)12.42M
Operating Cash Flow(11.81M)(23.88M)(17.96M)(19.78M)(26.68M)
Capital Expenditures(2.93M)(904K)(6.4M)(2.24M)(6.08M)
Acquisitions (Net)00000
Purchases of Investments000(125.08M)(70.49M)
Sales of Investments000148.19M55.98M
Other Investing Activities22.2M(89.03M)25.08M(103K)0
Investing Cash Flow19.27M(89.94M)18.68M20.77M(20.59M)
Debt Repayment00000
Common Stock Issued111K3.36M49K25K45.77M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities093.54M5.25M00
Financing Cash Flow111K96.91M5.3M25K45.77M
Effect of Forex Changes108K(258K)3.1M160K501K
Net Change in Cash7.68M(17.17M)9.12M1.17M(1M)
Free Cash Flow(14.74M)(24.78M)(24.36M)(22.02M)(32.76M)

Alpha Tau Medical Ltd.

NASDAQ:DRTS

Intrinsic Alpha fair value

Locked

Current Price

$12.01

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.